Related references
Note: Only part of the references are listed.SHH inhibitors for the treatment of medulloblastoma
Ayman Samkari et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
SHH inhibitors for the treatment of medulloblastoma
Ayman Samkari et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants
M. C. Buss et al.
ONCOGENE (2015)
Wip1 phosphatase in breast cancer
A. Emelyanov et al.
ONCOGENE (2015)
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Robert J. Vanner et al.
CANCER CELL (2014)
A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
Jordi Rodon et al.
CLINICAL CANCER RESEARCH (2014)
Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction
Aidan G. Gilmartin et al.
NATURE CHEMICAL BIOLOGY (2014)
WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function
S. Pandolfi et al.
ONCOGENE (2013)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
HDM2 promotes WIP1-mediated medulloblastoma growth
Meghan C. Buss et al.
NEURO-ONCOLOGY (2012)
WIP1 Enhances Tumor Formation in a Sonic Hedgehog-Dependent Model of Medulloblastoma
Tiffany A. Doucette et al.
NEUROSURGERY (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
p27Kip1, a double-edged sword in Shh-mediated medulloblastoma Tumor accelerator and suppressor
Bobby Bhatia et al.
CELL CYCLE (2010)
Universal Poor Survival in Children With Medulloblastoma Harboring Somatic TP53 Mutations
Uri Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Barbara Stecca et al.
EMBO JOURNAL (2009)
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91
Katja von Hoff et al.
EUROPEAN JOURNAL OF CANCER (2009)
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
Joel M. Hyman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma
Ulrich Schueller et al.
CANCER CELL (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
The Smo/Smo model: Hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread
Beryl A. Hatton et al.
CANCER RESEARCH (2008)
The Wip1 phosphatase and Mdm2: Cracking the Wip on p53 sta
Xiongbin Lu et al.
CELL CYCLE (2008)
Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors
Susana R. Parathath et al.
DEVELOPMENT (2008)
Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase
Akinori Yoda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
Yoshinori Abe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
S. Rayter et al.
ONCOGENE (2008)
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D
Robert C. Castellino et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Overexpressed TP73 induces apoptosis in medulloblastoma
Robert C. Castellino et al.
BMC CANCER (2007)
The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis
O. N. Demidov et al.
ONCOGENE (2007)
CellProfiler(TM): free, versatile software for automated biological image analysis
Michael R. Lamprecht et al.
BIOTECHNIQUES (2007)
Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice
Bonnie Nannenga et al.
MOLECULAR CARCINOGENESIS (2006)
Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma
TG Oliver et al.
DEVELOPMENT (2005)
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway
DV Bulavin et al.
NATURE GENETICS (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma
AJ Frank et al.
MOLECULAR BRAIN RESEARCH (2004)
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
AR Hallahan et al.
CANCER RESEARCH (2004)
Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors
AM Kenney et al.
DEVELOPMENT (2003)
Small molecule modulation of Smoothened activity
JK Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Classifying the medulloblastoma: insights from morphology and molecular genetics
D Ellison
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
DV Bulavin et al.
NATURE GENETICS (2002)
Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control
J Choi et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Share Paper
